Cargando…

Inhibitory Potential of Polyclonal Camel Antibodies against New Delhi Metallo-β-lactamase-1 (NDM-1)

New Delhi Metallo-β-lactamase-1 (NDM-1) is the most prevalent type of metallo-β-lactamase, able to hydrolyze almost all antibiotics of the β-lactam group, leading to multidrug-resistant bacteria. To date, there are no clinically relevant inhibitors to fight NDM-1. The use of dromedary polyclonal ant...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ben Abderrazek, Rahma, Chammam, Sarra, Ksouri, Ayoub, Perilli, Mariagrazia, Dhaouadi, Sayda, Mdini, Ines, Benlasfar, Zakaria, Amicosante, Gianfranco, Bouhaouala-Zahar, Balkiss, Piccirilli, Alessandra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7584030/ https://www.ncbi.nlm.nih.gov/pubmed/32998307 http://dx.doi.org/10.3390/molecules25194453

Ejemplares similares

Novel Human Tenascin-C Function-Blocking Camel Single Domain Nanobodies
por: Dhaouadi, Sayda, et al.
Publicado: (2021)

Neutralizing Dromedary-Derived Nanobodies Against BotI-Like Toxin From the Most Hazardous Scorpion Venom in the Middle East and North Africa Region
por: Ben Abderrazek, Rahma, et al.
Publicado: (2022)

Exploring the Role of L10 Loop in New Delhi Metallo-β-lactamase (NDM-1): Kinetic and Dynamic Studies
por: Piccirilli, Alessandra, et al.
Publicado: (2021)

Exploring the role of L209 residue in the active site of NDM-1 a metallo-β-lactamase
por: Marcoccia, Francesca, et al.
Publicado: (2018)

Wheat germ in vitro translation to produce one of the most toxic sodium channel specific toxins
por: Gad, Wael, et al.
Publicado: (2014)

Docking-Based Evidence for the Potential of ImmunoDefender: A Novel Formulated Essential Oil Blend Incorporating Synergistic Antiviral Bioactive Compounds as Promising Mpro Inhibitors against SARS-CoV-2
por: Ksouri, Ayoub, et al.
Publicado: (2023)

The Pharmacological and Structural Basis of the AahII–Na(V)1.5 Interaction and Modulation by the Anti-AahII Nb10 Nanobody
por: Hmaidi, Riadh, et al.
Publicado: (2022)

Polylactide Nanoparticles as a Biodegradable Vaccine Adjuvant: A Study on Safety, Protective Immunity and Efficacy against Human Leishmaniasis Caused by Leishmania Major
por: Ayari-Riabi, Sana, et al.
Publicado: (2022)

Novel Variant of New Delhi Metallo-β-lactamase, NDM-20, in Escherichia coli
por: Liu, Zhihai, et al.
Publicado: (2018)

Prediction of Phytochemicals for Their Potential to Inhibit New Delhi Metallo β-Lactamase (NDM-1)
por: Bibi, Zainab, et al.
Publicado: (2023)

Direct Amperometric Sensing of Fish Nodavirus RNA Using Gold Nanoparticle/DNA-Based Bioconjugates
por: Chérif, Nadia, et al.
Publicado: (2021)

Inhibitor Discovery of Full-Length New Delhi Metallo-β-Lactamase-1 (NDM-1)
por: Shen, Bingzheng, et al.
Publicado: (2013)

Corrigendum: Novel Variant of New Delhi Metallo-β-lactamase, NDM-20, in Escherichia coli
por: Liu, Zhihai, et al.
Publicado: (2018)

Oligopeptides as full-length New Delhi metallo-β-lactamase-1 (NDM-1) inhibitors
por: Shen, Bingzheng, et al.
Publicado: (2017)

In silico vaccine design and epitope mapping of New Delhi metallo-beta-lactamase (NDM): an immunoinformatics approach
por: Fathollahi, Matin, et al.
Publicado: (2021)

Identification of a New Delhi metallo-β-lactamase-4 (NDM-4)-producing Escherichia coli in Italy
por: Coppo, Erika, et al.
Publicado: (2014)

Local transmission and global dissemination of New Delhi Metallo-Beta-Lactamase (NDM): a whole genome analysis
por: Khong, Wei Xin, et al.
Publicado: (2016)

Structure, Genetics and Worldwide Spread of New Delhi Metallo-β-lactamase (NDM): a threat to public health
por: Khan, Asad U., et al.
Publicado: (2017)

On the Offensive: the Role of Outer Membrane Vesicles in the Successful Dissemination of New Delhi Metallo-β-lactamase (NDM-1)
por: Martínez, Melina M. B., et al.
Publicado: (2021)

Inpatient point-prevalence screening of New Delhi Metallo-β-lactamase (NDM)–producing Enterobacaterales and Candida auris
por: Greco, Christian, et al.
Publicado: (2022)

First detection of New Delhi metallo-β-lactamases variants (NDM-1, NDM-2) among Pseudomonas aeruginosa isolated from Iraqi hospitals
por: Ismail, Sarah Jehad, et al.
Publicado: (2018)

Discovery of thiosemicarbazone derivatives as effective New Delhi metallo-β-lactamase-1 (NDM-1) inhibitors against NDM-1 producing clinical isolates
por: Zhao, Bing, et al.
Publicado: (2021)

PHT427 as an effective New Delhi metallo-β-lactamase-1 (NDM-1) inhibitor restored the susceptibility of meropenem against Enterobacteriaceae producing NDM-1
por: Li, Xiaohui, et al.
Publicado: (2023)

Presence of New Delhi metallo-β-lactamase gene (NDM-1) in a clinical isolate of Acinetobacter junii in Argentina
por: Montaña, S., et al.
Publicado: (2016)

NDM-1 (New Delhi metallo beta lactamase-1) producing Gram-negative bacilli: Emergence & clinical implications
por: Fomda, Bashir Ahmad, et al.
Publicado: (2014)

Emergence of New Delhi Metallo-β-Lactamase (NDM-5) in Klebsiella quasipneumoniae from Neonates in a Nigerian Hospital
por: Brinkac, Lauren M., et al.
Publicado: (2019)

New Delhi Metallo-Beta-Lactamase (NDM-1)-Producing Klebsiella Pneumoniae Isolated from a Burned Patient
por: Petersen-Morfin, Santiago, et al.
Publicado: (2017)

Challenges of Multidrug-resistant New Delhi Metallo-beta-Lactamase (NDM-1)-producing Enterobacteriaceae in Kidney Transplant Patients
por: Foresto, Renato Demarchi, et al.
Publicado: (2021)

New Delhi Metallo-Beta-Lactamase (NDM)-5 in Uropathogenic Klebsiella pneumoniae in a Tertiary Care Hospital in Jamaica
por: Stone, Steven, et al.
Publicado: (2023)

High Prevalence of New Delhi Metallo-β-Lactamase-1 (NDM-1) Producers among Carbapenem-Resistant Enterobacteriaceae in Kuwait
por: Jamal, Wafaa Y., et al.
Publicado: (2016)

Risk factors and epidemiologic predictors of blood stream infections with New Delhi Metallo-b-lactamase (NDM-1) producing Enterobacteriaceae
por: Snyder, B. M., et al.
Publicado: (2019)

A Case of New Delhi Metallo-β-Lactamases (NDM) Citrobacter sedlakii Osteomyelitis Successfully Treated With Ceftazidime-Avibactam and Aztreonam
por: Rubnitz, Zachary A, et al.
Publicado: (2022)

New metallo β-lactamase NDM-1
por: Raghunath, D.
Publicado: (2010)

Detection of New Delhi metallo beta lactamase-1 (NDM-1) carbapenemase in Pseudomonas aeruginosa in a single centre in southern India
por: Shanthi, Mariappan, et al.
Publicado: (2014)

Draft Genome Sequence of the First New Delhi Metallo-β-Lactamase (NDM-1)-Producing Escherichia coli Strain Isolated in Peru
por: Tamariz, Jesus, et al.
Publicado: (2018)

New Delhi metallo-β-lactamase-1 (NDM-1) Escherichia coli isolated from household vacuum cleaner—Oregon, 2013
por: Buser, Genevieve L., et al.
Publicado: (2017)

Prolonged outbreak of New Delhi metallo-beta-lactamase-producing carbapenem-resistant Enterobacterales (NDM-CRE), Tuscany, Italy, 2018 to 2019
por: Tavoschi, Lara, et al.
Publicado: (2020)

Risedronate and Methotrexate Are High-Affinity Inhibitors of New Delhi Metallo-β-Lactamase-1 (NDM-1): A Drug Repurposing Approach
por: Muteeb, Ghazala, et al.
Publicado: (2022)

Draft Genome Sequence of a New Delhi Metallo-β-Lactamase-5 (NDM-5)-Producing Multidrug-Resistant Escherichia coli Isolate
por: de Man, Tom J. B., et al.
Publicado: (2015)

Comparative risk factors for nosocomial New Delhi metallo-beta-lactamase (NDM-1) producing Enterobacteriaceae and non-carbapenemase producing (NCP) Enterobacteriaceae
por: Izharuddin, E, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_r0moi4vbt9jflhrmuto5hj6pm4